Diagnostic Approach to Hepatosplenomegaly

Initial Evaluation

A complete blood count (CBC) is essential to assess for cytopenias, particularly thrombocytopenia, which may indicate portal hypertension or hematologic disorders in a patient with hepatosplenomegaly 1
Abdominal ultrasound provides a detailed assessment of liver and spleen morphology, helps identify focal lesions, and can detect signs of portal hypertension in patients with hepatosplenomegaly 2
Lipid profile testing can help identify mixed dyslipidemia with decreased HDL, which is common in storage disorders like acid sphingomyelinase deficiency (ASMD) 1, 3

Acid sphingomyelinase deficiency (ASMD) should be considered in the differential diagnosis of hepatosplenomegaly in young adults, as it commonly presents with hepatosplenomegaly and normal liver function tests (LFTs) 1, 4
Other storage disorders to consider include Gaucher disease, Niemann-Pick disease type C, and lysosomal acid lipase deficiency (LALD) 3

Hematologic disorders, such as leukemia and lymphoma, should be considered in the differential diagnosis of hepatosplenomegaly 5
Cystic fibrosis hepatobiliary involvement can cause hepatosplenomegaly and should be considered in the differential diagnosis 2

Genetic testing, particularly for the SMPD1 gene, should be considered if there is a high clinical suspicion of ASMD 4, 6
Liver elastography can be used to assess for fibrosis in patients with hepatosplenomegaly, if available 2
Chest X-ray or CT can be used to evaluate for pulmonary involvement, especially if ASMD is suspected 1
Bone marrow biopsy may be considered if hematologic disorders are suspected or to identify storage cells 6

Splenomegaly in ASMD can be massive (>10x normal size) and may precede hepatomegaly 7
In young adults with unexplained hepatosplenomegaly, ASMD often has a 4+ year delay in diagnosis due to its rarity 6
Pulmonary function testing should be considered, as interstitial lung disease commonly accompanies ASMD 3

Abdominal ultrasound should be used to confirm and characterize hepatosplenomegaly 2
Liver fibrosis indices, such as APRI, FIB-4, and GGT-to-Platelet Ratio, can be calculated to assess for advanced fibrosis 8

Doppler ultrasonography provides valuable information about portal blood flow and can detect portal hypertension by identifying reduced portal blood flow velocity, loss of respiratory changes in portal flow, or portal blood flow reversal, as recommended by the American Association for the Study of Liver Diseases 9, 10
Computed tomography (CT) or MRI can provide detailed assessment of liver and spleen morphology and detect portosystemic shunting, according to the European Association for the Study of the Liver 9, 11

Vibration-controlled transient elastography (VCTE) can assess liver stiffness and has excellent diagnostic performance for clinically significant portal hypertension with a hierarchical summary AUC of 0.90, as reported by the American Association for the Study of Liver Diseases 9, 12
The LSPS score (combining liver stiffness, spleen size, and platelet count) improves diagnostic accuracy for portal hypertension, as recommended by the American Association for the Study of Liver Diseases 9, 12
Hepatic venous pressure gradient (HVPG) measurement is the gold standard for assessing portal hypertension but is invasive and limited to specialized centers, according to the American Association for the Study of Liver Diseases 9
Liver biopsy can be helpful in cases where non-invasive tests are inconclusive, but should be avoided in suspected hereditary hemorrhagic telangiectasia due to bleeding risk, as advised by the European Association for the Study of the Liver 10, 11

Serum markers alone (APRI, FIB-4, Forns index, Lok score) have limitations in evaluating portal hypertension and should be combined with imaging findings, as reported by the American Association for the Study of Liver Diseases 9, 12
In young adults with unexplained hepatosplenomegaly, consider acid sphingomyelinase deficiency (ASMD) which often has a delayed diagnosis due to its rarity, according to the American College of Medical Genetics and Genomics 13